China SXT Pharmaceuticals (SXTC) Long-Term Deferred Tax (2018 - 2025)
Historic Long-Term Deferred Tax for China SXT Pharmaceuticals (SXTC) over the last 4 years, with Q1 2021 value amounting to $321444.0.
- China SXT Pharmaceuticals' Long-Term Deferred Tax rose 18486.96% to $321444.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $321444.0, marking a year-over-year increase of 18486.96%. This contributed to the annual value of $321444.0 for FY2021, which is 18486.96% up from last year.
- According to the latest figures from Q1 2021, China SXT Pharmaceuticals' Long-Term Deferred Tax is $321444.0, which was up 18486.96% from $23367.0 recorded in Q3 2020.
- In the past 5 years, China SXT Pharmaceuticals' Long-Term Deferred Tax registered a high of $321444.0 during Q1 2021, and its lowest value of $6174.0 during Q1 2018.
- Its 4-year average for Long-Term Deferred Tax is $81667.8, with a median of $18435.5 in 2019.
- Over the last 5 years, China SXT Pharmaceuticals' Long-Term Deferred Tax had its largest YoY gain of 73559.69% in 2020, and its largest YoY loss of 8429.69% in 2020.
- Quarter analysis of 4 years shows China SXT Pharmaceuticals' Long-Term Deferred Tax stood at $6174.0 in 2018, then soared by 105.36% to $12679.0 in 2019, then soared by 84.3% to $23367.0 in 2020, then skyrocketed by 1275.63% to $321444.0 in 2021.
- Its Long-Term Deferred Tax was $321444.0 in Q1 2021, compared to $23367.0 in Q3 2020 and $112839.0 in Q1 2020.